SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-24-000121
Filing Date
2024-08-01
Accepted
2024-08-01 09:49:09
Documents
70
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20240630.htm   iXBRL 10-Q 1272350
2 EX-10.1 exhibit101.htm EX-10.1 339213
3 EX-31.1 exhibit31-1x06x30x24.htm EX-31.1 9702
4 EX-31.2 exhibit31-2x06x30x24.htm EX-31.2 9713
5 EX-32.1 exhibit32-1x06x30x24.htm EX-32.1 4695
6 EX-32.2 exhibit32-2x06x30x24.htm EX-32.2 4690
  Complete submission text file 0001439222-24-000121.txt   6347203

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20240630.xsd EX-101.SCH 41007
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20240630_cal.xml EX-101.CAL 66455
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20240630_def.xml EX-101.DEF 155244
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20240630_lab.xml EX-101.LAB 547957
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20240630_pre.xml EX-101.PRE 374907
73 EXTRACTED XBRL INSTANCE DOCUMENT agio-20240630_htm.xml XML 740296
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 241164807
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)